Cellectis (CLLS) Capital Expenditures: 2018-2023
Historic Capital Expenditures for Cellectis (CLLS) over the last 6 years, with Dec 2023 value amounting to $9.4 million.
- Cellectis' Capital Expenditures fell 12.75% to $9.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.1 million, marking a year-over-year decrease of 55.86%. This contributed to the annual value of $2.6 million for FY2024, which is 140.73% up from last year.
- Per Cellectis' latest filing, its Capital Expenditures stood at $9.4 million for Q4 2023, which was up 438.07% from -$2.8 million recorded in Q3 2023.
- In the past 5 years, Cellectis' Capital Expenditures registered a high of $53.7 million during Q4 2020, and its lowest value of -$6.0 million during Q3 2020.
- Over the past 3 years, Cellectis' median Capital Expenditures value was -$2.8 million (recorded in 2023), while the average stood at $1.8 million.
- As far as peak fluctuations go, Cellectis' Capital Expenditures crashed by 5,296.15% in 2019, and later skyrocketed by 248.13% in 2020.
- Quarterly analysis of 5 years shows Cellectis' Capital Expenditures stood at $15.4 million in 2019, then soared by 248.13% to $53.7 million in 2020, then crashed by 47.86% to $28.0 million in 2021, then plummeted by 61.49% to $10.8 million in 2022, then decreased by 12.75% to $9.4 million in 2023.
- Its last three reported values are $9.4 million in Q4 2023, -$2.8 million for Q3 2023, and -$2.8 million during Q2 2023.